Vor Biopharma Inc. — Director's Dealing 2021

Feb 5, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Vor Biopharma Inc. (VOR)
CIK: 0001817229
Period of Report: 2021-02-04

Reporting Person: ANG ROBERT (Director, President and CEO)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	412072	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (right to buy)	$2.18	2030-03-09	Common Stock (147293)		Direct
Employee Stock Option (right to buy)	$1.90	2030-08-20	Common Stock (652086)		Direct

Footnotes

F1: 1/4th of the shares underlying the option vested on August 5, 2020, with the remainder vesting in equal monthly installments over 3 years, provided that the Reporting Person remains continuously engaged by the Issuer on each such vesting date.

F2: 1/24th of the shares underlying the option vested on September 1, 2020, with the remainder vesting in equal monthly installments over 46 months,
provided that the Reporting Person remains continuously engaged by the Issuer on each such vesting date.